“Is this email relevant to you” Question + Survey (Afstyla) Feb 18, 2019Feb 21, 2019 Brand: Afstyla (antihemophilic factor), Intravenous Infusion Parent Company: CSL Behring Drug Type: Prescription Drug Category: Hematology Campaign: Launch Targeting: Patients, Caregivers Patient Website: https://www.afstyla.com/ HCP Website: https://www.afstyla.com/ Is this email relevant? Mini Survey Thank You Page